Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related
Published: September 18 2023
Abstract Views: 809
PDF: 271
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
Authors
We thank Finsterer et al. for the attention paid to our publication; we recognize the validity of the points mentioned in their letter to the editor and will try to answer the observations made.
Altmetrics
Downloads
Download data is not yet available.
Citations
Finsterer J, MohanaSundaram AS, Scorza F. Myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related. Reumatismo 2023, 75:(3). doi: 10.4081/reumatismo.2023.1601. DOI: https://doi.org/10.4081/reumatismo.2023.1601
Al-Rasbi S, Al-Maqbali JS, Al-Farsi R, Al Shukaili MA, Al-Riyami MH, Al Falahi Z, et al. Myocarditis, pulmonary hemorrhage, and extensive myositis with rhabdomyolysis 12 days after first dose of Pfizer-Biontech BNT162b2 mRNA covid-19 vaccine: a case report. Am J Case Rep 2022; 23: e934399. DOI: https://doi.org/10.12659/AJCR.934399
Rodrigues de Carvalho M, Sá de Deus Rocha MM, Alves Bezerra V, de Pontes ME, Del Negro MC, Antunes JS, et al. Anti-3-hydroxy-3-methylglutaryl-coenzyme a reductase immune-mediated necrotizing myopathy following mRNA SARS-CoV-2 vaccination. Case Rep Neurol Med 2023; 2023: 7061783 DOI: https://doi.org/10.1155/2023/7061783
Syrmou V, Liaskos C, Ntavari N, Mitsimponas K, Simopoulou T, Alexiou I, et al. Covid-19 vaccine-associated myositis: a comprehensive review of the literature driven by a case report. Immunol Res 2023; 16: 1-10. DOI: https://doi.org/10.1007/s12026-023-09368-2
Chang CH, Gupta R, Setyono D, Cuevas-Ocampo AK, Khoshnoodi MA. Refractory seronegative immune-mediated necrotizing myopathy after receiving mRNA-1273 SARS-CoV-2 vaccine: a case report. J Clin Neuromuscul Dis 2023; 24: 168-9. DOI: https://doi.org/10.1097/CND.0000000000000431
Camargo Coronel A, Jiménez Balderas FJ, Quiñones Moya H, Hernández Zavala MR, Mandinabeitia Rodríguez P, Ramiro Hernández J, et al. Dermatomyositis post vaccine against SARS-COV2. BMC Rheumatol 2022; 6: 20. DOI: https://doi.org/10.1186/s41927-022-00250-6
How to Cite
Response to: myositis after SARS-CoV-2 vaccination occurs more frequently than assumed and is probably causally related. (2023). Reumatismo, 75(3). https://doi.org/10.4081/reumatismo.2023.1623
Copyright (c) 2023 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Similar Articles
- L. Bogliolo, G. Crepaldi, R. Caporali, Biomarkers and prognostic stratification in psoriatic arthritis , Reumatismo: Vol. 64 No. 2 (2012)
- L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita, Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis , Reumatismo: Vol. 61 No. 3 (2009)
- B. Palterer, G. Vitiello, D. Cammelli, First report of anti-TIF1γ dermatomyositis in a patient with myelodysplastic syndrome , Reumatismo: Vol. 69 No. 2 (2017)
- A. Notarnicola, G. Lapadula, D. Natuzzi, F. Iannone, Possible interplay between interleukin-15 and interleukin-17 into the pathogenesis of idiopathic inflammatory myopathies , Reumatismo: Vol. 66 No. 3 (2014)
- T. Ulas, H. Buyukhatipoglu, C. Bes, M.S. Dal, I. Hacıbekiroglu, H.G. Apucu, F. Borlu, Familial Mediterranean fever without cardinal symptoms and role of genetic screening , Reumatismo: Vol. 64 No. 3 (2012)
- L. Iaccarino, A. Ghirardello, M. Zen, D. Villalta, A. Tincani, L. Punzi, A. Doria, Polarization of TH2 response is decreased during pregnancy in systemic lupus erythematosus , Reumatismo: Vol. 64 No. 5 (2012)
- C. Botsios, P. Sfriso, A. Furlan, P. Ostuni, M. Biscaro, U. Fiocco, S. Todesco, L. Punzi, Anakinra, a recombinant human IL-1 receptor antagonist, in clinical practice. Outcome in 60 patients with severe rheumatoid arthritis , Reumatismo: Vol. 59 No. 1 (2007)
- R. Talotta, A. Berzi, F. Atzeni, D. Dell'Acqua, P. Sarzi Puttini, D. Trabattoni, Evaluation of Th9 lymphocytes in peripheral blood of rheumatoid arthritis patients and correlation with anti-tumor necrosis factor therapy: results from an in vitro pivotal study , Reumatismo: Vol. 68 No. 2 (2016)
- I. Bertoldi, B. Frediani, Osteoarthritis and osteoporosis: correlations between two clinical entities , Reumatismo: Vol. 65 No. 2 (2013)
- L. Bazzichi, D. Biasi, E. Tinazzi, M. Muratore, R. Pellerito, R. Russo, M. Corsaro Santi, P. De Sandre, O. Epis, M. Granata, B. Kroegler, C. Meschini, F. Versace, C. Astolfi, Safety of rituximab in the routine treatment of rheumatoid arthritis in Italy in patients refractory to anti-TNFa drugs: results from the observational retrospective-prospective RUBINO study , Reumatismo: Vol. 66 No. 3 (2014)
You may also start an advanced similarity search for this article.
